Literature DB >> 30289736

Examination of Health System Resources and Costs Associated With Transitioning Cancer Survivors to Primary Care: A Propensity-Score-Matched Cohort Study.

Nicole Mittmann1, Hasmik Beglaryan1, Ning Liu1, Soo Jin Seung1, Farah Rahman1, Julie Gilbert1, Stefanie De Rossi1, Craig C Earle1, Eva Grunfeld1, Victoria Zwicker1, Dominique LeBlanc1, Jonathan Sussman1.   

Abstract

BACKGROUND: : Transitioning low-risk cancer survivors back to their primary care provider (PCP) has been shown to be safe but the effect on health system resources and costs has not been examined.
METHODS: : A Well Follow-Up Care Initiative (WFCI) was implemented in the publicly funded health system. Low-risk breast cancer (BC) survivors in the WFCI intervention group were transitioned from oncologist-led cancer clinics to PCPs. We compared health system costs ($2,014 in Canadian dollars) and resource utilization in this intervention group with that in propensity-score-matched nontransitioned BC survivors (ie, controls) diagnosed in the same year, with similar disease profile and patient characteristics using publicly funded administrative databases.
RESULTS: : A total of 2,324 BC survivors from the WFCI intervention group were 1:1 matched to controls and observed for 25 months. Compared with controls, survivors in the intervention group incurred a similar number of PCP visits (6.9 v 7.5) and fewer oncologist visits (0.3 v 1.2) per person-year. Fewer survivors in the intervention group (20.1%) were hospitalized than in the control group (24.4%). There were no differences in emergency visits. More survivors in the intervention group had mammograms (82.6% v 73.1%), but other diagnostic tests were less frequent. There was a 39.3% reduction in overall mean annual costs ($6,575 v $10,832) and a 22.1% reduction in overall median annual costs ($2,261 v $2,903). Overall survival in the intervention group was not worse than controls.
CONCLUSION: : Transitioning low-risk BC survivors to PCPs was associated with lower health system resource use and a lower annual cost per patient than matched controls. The WFCI model represents a reasonable approach at the population level to delivering quality care for low-risk BC survivors that seems to be cost effective.

Entities:  

Year:  2018        PMID: 30289736     DOI: 10.1200/JOP.18.00275

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


  7 in total

Review 1.  Personalized Risk-Stratified Cancer Follow-Up Care: Its Potential for Healthier Survivors, Happier Clinicians, and Lower Costs.

Authors:  Deborah K Mayer; Catherine M Alfano
Journal:  J Natl Cancer Inst       Date:  2019-05-01       Impact factor: 13.506

2.  The generation of two specific cancer costing algorithms using Ontario administrative databases.

Authors:  N Mittmann; S Y Cheng; N Liu; S J Seung; F E Saxena; C DeAngelis; N J Look Hong; C C Earle; M C Cheung; N Leighl; N Coburn; W K Evans
Journal:  Curr Oncol       Date:  2019-10-01       Impact factor: 3.677

3.  Risk Stratification and Cancer Follow-Up: Towards More Personalized Post-Treatment Care in Canada.

Authors:  Robin Urquhart; Wendy Cordoba; Jackie Bender; Colleen Cuthbert; Julie Easley; Doris Howell; Julia Kaal; Cynthia Kendell; Samantha Radford; Jonathan Sussman
Journal:  Curr Oncol       Date:  2022-05-03       Impact factor: 3.109

4.  Adherence to Surveillance for Second Malignant Neoplasms and Cardiac Dysfunction in Childhood Cancer Survivors: A Childhood Cancer Survivor Study.

Authors:  Adam P Yan; Yan Chen; Tara O Henderson; Kevin C Oeffinger; Melissa M Hudson; Todd M Gibson; Joseph P Neglia; Wendy M Leisenring; Kirsten K Ness; Jennifer S Ford; Leslie L Robison; Gregory T Armstrong; Yutaka Yasui; Paul C Nathan
Journal:  J Clin Oncol       Date:  2020-03-06       Impact factor: 44.544

5.  Personalized Cancer Follow-Up Care Pathways: A Delphi Consensus of Research Priorities.

Authors:  Corinne R Leach; Catherine M Alfano; Jessica Potts; Lisa Gallicchio; K Robin Yabroff; Kevin C Oeffinger; Erin E Hahn; Lawrence N Shulman; Shawna V Hudson
Journal:  J Natl Cancer Inst       Date:  2020-12-14       Impact factor: 13.506

6.  Prevalence and determinants of depression up to 5 years after colorectal cancer surgery: results from the ColoREctal Wellbeing (CREW) study.

Authors:  Lynn Calman; Joshua Turner; Deborah Fenlon; Natalia V Permyakova; Sally Wheelwright; Mubarak Patel; Amy Din; Jane Winter; Alison Richardson; Peter W F Smith; Claire Foster
Journal:  Colorectal Dis       Date:  2021-11-25       Impact factor: 3.917

7.  Gene Expression Profiling Tests for Early-Stage Invasive Breast Cancer: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2020-03-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.